Ronald T Gansevoort

45PUBLICATIONS
136CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 08, 2026
Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

|May 27, 2026
Efficacy and safety of the cystic fibrosis transmembrane conductance regulator inhibitor GLPG2737 for autosomal dominant polycystic kidney disease: phase 2a MANGROVE study.

|May 11, 2026
Measuring the Impact of tolvaptan-induced polyuria on quality of life in patients with autosomal dominant polycystic kidney disease.

|May 05, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.

|Apr 24, 2026
Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials.

|Apr 24, 2026
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria A consensus report of the USA NKF Albuminuria - Proteinuria Workshop.

Pageof 8

Frequent Collaborators

9 joint publications

Hiddo J L Heerspink

8 joint publications

Stephan J L Bakker

7 joint publications

Luuk B Hilbrands

6 joint publications

Alberto Ortiz